• From Alchemy to IPO: The Business of Biotechnology See large image

    From Alchemy to IPO: The Business of Biotechnology (Paperback) By (author) Cynthia Robbins-Roth

    Hard to find title available from Book Depository

    $13.58 - Save $3.92 22% off - RRP $17.50 Free delivery worldwide Available
    Dispatched in 4 business days
    When will my order arrive?
    Add to basket | Add to wishlist |

    Description"A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth."-Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers"From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can."-George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, AmgenWritten by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.


Other books

Other people who viewed this bought | Other books in this category
Showing items 1 to 10 of 10

 

Reviews | Bibliographic data
  • Full bibliographic data for From Alchemy to IPO

    Title
    From Alchemy to IPO
    Subtitle
    The Business of Biotechnology
    Authors and contributors
    By (author) Cynthia Robbins-Roth
    Physical properties
    Format: Paperback
    Number of pages: 272
    Width: 152 mm
    Height: 229 mm
    Thickness: 15 mm
    Weight: 385 g
    Language
    English
    ISBN
    ISBN 13: 9780738204826
    ISBN 10: 073820482X
    Classifications

    B&T Merchandise Category: GEN
    B&T Book Type: NF
    BIC E4L: TEC
    Nielsen BookScan Product Class 3: T8.9
    LC subject heading:
    BIC subject category V2: HBT
    B&T Modifier: Academic Level: 05
    BIC subject category V2: KNDC
    B&T Modifier: Subject Development: 10
    LC subject heading:
    B&T General Subject: 180
    Ingram Subject Code: BE
    Libri: I-BE
    Warengruppen-Systematik des deutschen Buchhandels: 26780
    BISAC V2.8: BUS069000, SCI010000
    BIC subject category V2: TCB
    BISAC V2.8: BUS048000
    LC subject heading:
    B&T Approval Code: A48203000
    BISAC V2.8: BUS070000
    DC22: 338.476606
    DC21: 338.476606
    LC subject heading:
    B&T Approval Code: B94720000
    DC22: 660.6/068/1
    LC classification: TP248.2 .R63 2001
    Thema V1.0: TCB, NHT, KND
    Publisher
    The Perseus Books Group
    Imprint name
    PERSEUS BOOKS
    Publication date
    11 April 2001
    Publication City/Country
    Reading, MA
    Author Information
    Cynthia Robbins-Roth, Ph.D., is the founder of BioVenture Consultants, which provides strategic planning and financial assessment to biotech start-ups, pharmaceutical companies, and venture-capital firms. Her biotech column appears regularly in Forbes magazine, and Forbes ASAP recently named her one of the top twenty-five biotech all-stars of 1999. She lives in San Mateo, California.
    Review quote
    "A fascinating glimpse inside the life-and-death business of biotechnology. A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth." -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers "From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can." -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen"